Clinical Trials Browser

Recruiting × Melanoma × Vaccines × Clear all

NCT05264974 2026-01-21

Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Phase 1 Recruiting

DermatologicSarcoma

Melanoma, Sarcoma